Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Summary
The Managing Director of CNS, Russell Neal, commented, “We are absolutely delighted to be joining up with a life sciences investor and corporate consultancy of the standing of Ventac Partners.With our team come more than 200 years of international practical experience in growing good technology into successful businesses, both as entrepreneurs in start-up companies and as management in large pharma enterprises and CROs.CNS and BioDesk bring to our team top level regulatory expertise and clinical trial management, which will be of critical importance to our maturing portfolio and client companies.”About Ventac PartnersVentac Partners is a dedicated life science consulting firm with offices in Europe, USA and Asia.With our team come more than 200 years of international practical experience in growing good technology into successful businesses, both as entrepreneurs in start-up companies and as management in large pharma enterprises and CROs.Further information about CNS and its intelligent development services can be found at www.clinical.net.auAbout BioDeskCNS’s BioDesk is an expert consulting team offering manufacturing, toxicology, clinical and regulatory affairs consulting services for readying products to enter clinical trials or marketing approval.The BioDesk team consists of experienced chemists, toxicologists, medical writers, regulatory affairs specialists and experienced clinicians based in Australia, Europe and the USA.